
cautiou outlook strateg review reduc visibl bioag due sever
pressur us farm sector rel cautiou stanc impact us
initi bioenergi like keep share range-bound least
ep forecast gross profit sg
 incom net financi lower tax
minor interest organ sale rose food beverag
bioenergi household ag feed technic pharma
region organ growth asia north america emea
latin america
weak household mostli ascrib global custom cost
optim weak middl east linger believ
increas pressur dowdupont dwdp buy like also factor could
persist bioenergi momentum continu better expect
despit us product ethanol high inventori like
spill well regulatori trend brazil china appear like
drive acceleraton chines appear relev
enogen potenti threat still appear limit impact -- better
expect weak ag feed mostli due weak anim feed wherea
bioag appear trend slightli ahead expect acceleron
sold acr capital-expenditure work capit appear like
benign expect lift target balanciu
feed market appear path peak sale favor legisl
brazil support expans ethanol product yoy anoth increas
next year wherea estim volum gain would like add
best us ethanol volum new balanciu gut health
enzym chicken estim potenti peak sale still
expect key product launch hygien target
busi
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
valu bioag agreement dkk npv blend
base case high case
valu core busi ep dkk
equival ep ebitda
bioag worth dkk high case
trade better organ growth dkk
lever buyback dkk
equival ep
valu balanc pipelin
trade dkk
invest case novozym hing restor
growth rate core enzym busi
commerci cellulos ethanol enzymat
hydrolysi roll bioag platform
develop biochem biopharma platform
acceler growth middl decad
demonstr oper leverag bioag
traction bioenergi outsid us
pleas see import disclosur inform page report
financi summari market data
estim valuat
pleas see import disclosur inform page report
pleas see import disclosur inform page report
base denmark novozym market leader industri enzym microorgan compani sale
dkk novozym two oper segment enzym busi sale biobusi use
ferment technolog compani grow microorgan larg vat one organ multipli trillion hour
organ produc enzym protein novozym
arriv price target valu busi base ratio balanc driven sotp
analysi long-term growth opportun lion share bioag segment risk price competit low cost
countri china india etoh substitut volatil deterg channel emerg market consum demand
price target dowdupont reflect sector regress impli dowdupont trade ep risk includ
soften demand tighter ethane-naphtha spread
laurenc alexand cfa certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
daniel rizzo certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
nichola cecero certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate
secur averag secur price consist expect total return price appreci plu yield plu minu
within period under-perform rate secur averag secur price consist expect
total return price appreci plu yield minu less within period
pleas see import disclosur inform page report
